AbbVie Inc. is 47.4x more valuable than CORCEPT THERAPEUTICS INC by market capitalization ($397.44 B vs $8.39 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CORT | ABBV |
|---|---|---|
| Market cap | $8.39 B | $397.44 B |
| US-listed rank | #1039 | #28 |
| Revenue (latest FY) | $761.41M | $61.16B |
| Net income (latest FY) | $99.65M | $4.23B |
| Net margin | 13.1% | 6.9% |
| P/E (trailing FY) | 84.2 | 94.0 |
| SEC filings | 1,955 | 1,008 |
AbbVie Inc. is 47.4x more valuable than CORCEPT THERAPEUTICS INC by market capitalization ($397.44 B vs $8.39 B).
In their latest fiscal years, CORCEPT THERAPEUTICS INC reported $761.41M in revenue while AbbVie Inc. reported $61.16B.
Full pages: CORCEPT THERAPEUTICS INC and AbbVie Inc., or browse the full rankings.